NO20055749L - Sulfamat benzotiofenderivater som steroid sulfatase inhibitorer - Google Patents

Sulfamat benzotiofenderivater som steroid sulfatase inhibitorer

Info

Publication number
NO20055749L
NO20055749L NO20055749A NO20055749A NO20055749L NO 20055749 L NO20055749 L NO 20055749L NO 20055749 A NO20055749 A NO 20055749A NO 20055749 A NO20055749 A NO 20055749A NO 20055749 L NO20055749 L NO 20055749L
Authority
NO
Norway
Prior art keywords
steroid sulfatase
benzothiophene derivatives
sulfatase inhibitors
sulfamate benzothiophene
sulfamate
Prior art date
Application number
NO20055749A
Other languages
English (en)
Other versions
NO20055749D0 (no
Inventor
Paule Bonnet
Denis Carniato
Jean Lafay
Benoit Rondot
Thierry Clerc
Jacqueline Shields
Igor Duc
Eric Duranti
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theramex filed Critical Theramex
Publication of NO20055749D0 publication Critical patent/NO20055749D0/no
Publication of NO20055749L publication Critical patent/NO20055749L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/76—Dibenzothiophenes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Materials For Photolithography (AREA)

Abstract

Det er beskrevet sulfamatbenzotiofenforbindelser med formel (I) hvor R1, R2, R3, m og n er som definert i beskrivelsen. Oppfinnelsen vedrører også farmasøytiske sammensetninger inneholdende disse forbindelsene og fremgangsmåter for anvendelse av disse.
NO20055749A 2003-05-16 2005-12-05 Sulfamat benzotiofenderivater som steroid sulfatase inhibitorer NO20055749L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2003/008811 WO2004101545A1 (en) 2003-05-16 2003-05-16 Sulfamate benzothiophene derivatives as steroid sulfatase inhibitors

Publications (2)

Publication Number Publication Date
NO20055749D0 NO20055749D0 (no) 2005-12-05
NO20055749L true NO20055749L (no) 2005-12-14

Family

ID=33442621

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055749A NO20055749L (no) 2003-05-16 2005-12-05 Sulfamat benzotiofenderivater som steroid sulfatase inhibitorer

Country Status (21)

Country Link
US (1) US7476691B2 (no)
EP (1) EP1644350B1 (no)
JP (1) JP4757497B2 (no)
CN (2) CN101508691A (no)
AP (1) AP2066A (no)
AT (1) ATE435221T1 (no)
AU (1) AU2003260390B2 (no)
BR (1) BR0318295A (no)
CA (1) CA2525684C (no)
CY (1) CY1109371T1 (no)
DE (1) DE60328233D1 (no)
DK (1) DK1644350T3 (no)
ES (1) ES2329241T3 (no)
IL (1) IL171763A (no)
MX (1) MXPA05012300A (no)
NO (1) NO20055749L (no)
NZ (1) NZ544013A (no)
PT (1) PT1644350E (no)
SI (1) SI1644350T1 (no)
TN (1) TNSN05291A1 (no)
WO (1) WO2004101545A1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005058842A1 (en) 2003-12-15 2005-06-30 Laboratoire Theramex 1-n-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them
GB0511190D0 (en) * 2005-06-01 2005-07-06 Sterix Ltd Use
EP2035405A1 (de) * 2006-07-05 2009-03-18 Merck Patent GmbH Sulfamat-benzothiophen-derivate
RU2424237C2 (ru) * 2006-08-31 2011-07-20 Лаборатуар Терамекс Сульфаматпроизводные бензотиофена в качестве ингибиторов стероидной сульфатазы
CA2671311A1 (en) * 2006-12-04 2008-06-12 Wolfgang Staehle Sulfamatobenzothiophene derivatives
US20100204146A1 (en) * 2007-09-17 2010-08-12 Preglem S.A. Treatment of Oestrogen Dependant Conditions in Pre-menopausal Women
JP2011157371A (ja) * 2011-03-17 2011-08-18 Lab Theramex ステロイドスルファターゼ阻害剤としてのベンゾチオフェンスルファミン酸塩誘導体
CN115805103B (zh) * 2021-09-14 2024-04-09 万华化学集团股份有限公司 一种失活钛硅分子筛的再生方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9118478D0 (en) * 1991-08-29 1991-10-16 Imperial College Steroid sulphatase inhibitors
US6248780B1 (en) * 1998-10-01 2001-06-19 Duquesne University Of The Holy Ghost Compounds for the treatment of estrogen-dependent illnesses and methods for making and using the same
JP4320089B2 (ja) * 1999-07-06 2009-08-26 あすか製薬株式会社 フェニルスルファメート誘導体

Also Published As

Publication number Publication date
DK1644350T3 (da) 2009-11-23
CA2525684C (en) 2015-01-06
NZ544013A (en) 2009-04-30
HK1087115A1 (zh) 2006-10-06
WO2004101545A1 (en) 2004-11-25
US7476691B2 (en) 2009-01-13
CN100491370C (zh) 2009-05-27
CN1771243A (zh) 2006-05-10
DE60328233D1 (de) 2009-08-13
AU2003260390A1 (en) 2004-12-03
TNSN05291A1 (en) 2007-07-10
JP2006525947A (ja) 2006-11-16
AP2066A (en) 2009-11-27
SI1644350T1 (sl) 2009-12-31
ES2329241T3 (es) 2009-11-24
JP4757497B2 (ja) 2011-08-24
PT1644350E (pt) 2009-09-02
CY1109371T1 (el) 2014-07-02
IL171763A (en) 2013-09-30
US20070021492A1 (en) 2007-01-25
MXPA05012300A (es) 2006-01-30
CA2525684A1 (en) 2004-11-25
EP1644350A1 (en) 2006-04-12
BR0318295A (pt) 2006-07-11
NO20055749D0 (no) 2005-12-05
CN101508691A (zh) 2009-08-19
EP1644350B1 (en) 2009-07-01
ATE435221T1 (de) 2009-07-15
AU2003260390B2 (en) 2010-05-20
AP2005003468A0 (en) 2005-12-31

Similar Documents

Publication Publication Date Title
NO20050828L (no) lndol-3-svovelderivater
NO20066055L (no) Pyridinderivater
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
NO20051100L (no) Pyrazolsammensetninger anvendelige som GSK-3-inhibitorer
NO20070555L (no) Kinazolinonderivater som parp-inhibitorer
NO20070557L (no) Ftalazinderivater som PARP-inhibitorer
NO20070529L (no) Kinazolindionderivater som parp-inhibitorer
NO20025601L (no) Arylmetylaminderivater for anvendelse som tryptaseinhibitorer
DE60328010D1 (de) Heterocyclische verbindungen
NO20071593L (no) Pyrimidinderivater
NO20054905L (no) 2-acylamino-4-fenyltiazolderivater, fremgangsmate for deres fremstilling og anvendelse av de samme som i terapeutika
DK1268471T3 (da) N-heterocykliske derivater som NOS-inhibitorer
NO20056192L (no) Kapaseinhibitorer og anvendelse derav
NO20081001L (no) Derivater av karboksamid som antagonister for muskarinisk reseptor
DE60313350D1 (de) Pyrimidin-2,4-dion-derivate als matrix-metalloproteinase-hemmer
NO20054787L (no) Indenderivater som farmasotiske midler
IL173810A0 (en) Imidazopyridine derivatives and pharmaceutical compositions containing the same
CY1109371T1 (el) Παραγωγα σουλφαμικου βενζοθειοφαινιου ως αναστολεις σουλφατασης στεροειδους
EA200600100A1 (ru) Производные никотинамида, полезные в качестве ингибиторов pde4
NO20072078L (no) Indolderivater som inhibitorer av loselig adenylsyklase
ATE419242T1 (de) Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren
NO20064351L (no) Caspaseinhibitorer og anvendelser derav
NO20062533L (no) 5-fluor, 5-klor- og cyanopyridin-2-yl-tetrazoler som ligander for den metabotrofe glutamatreseptor-5
NO20061789L (no) Aminopyridinderivater som induserbare NO-syntaseinhibitorer
ATE462703T1 (de) Bicyclononen-derivate als renin-inhibitoren

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application